Autolus Therapeutics plc — All Filings
296 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
20-F/A
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
NT 10-Q
POS AM
POSASR
S-1
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D | SC 13D | 0001193125-24-041581 | Feb 21, 2024 | — |
| SC 13G/A | — | 0001172661-24-001250 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-000912 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023621 | Feb 14, 2024 | — |
| 8-K | 8-K | 0001193125-24-033690 | Feb 13, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-034072 | Feb 13, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-030300 | Feb 9, 2024 | — |
| 8-K | 8-K | 0001193125-24-028372 | Feb 8, 2024 | — |
| 8-K | 8-K | 0001193125-24-027393 | Feb 8, 2024 | Feb 6, 2024 |
| S-3ASR | S-3ASR | 0001193125-24-027180 | Feb 8, 2024 | — |
| SC 13G/A | AUTOLUS THERAPEUTICS PLC | 0000902664-24-000837 | Jan 31, 2024 | — |
| 8-K | 8-K | 0001730463-24-000007 | Jan 26, 2024 | Jan 22, 2024 |
| 8-K | 8-K | 0001730463-24-000004 | Jan 10, 2024 | Jan 9, 2024 |
| 8-K | 8-K | 0001730463-23-000125 | Dec 22, 2023 | Dec 19, 2023 |
| 8-K | 8-K | 0001730463-23-000119 | Dec 11, 2023 | Dec 9, 2023 |
| 8-K | 8-K | 0001730463-23-000115 | Nov 27, 2023 | — |
| 8-K | 8-K | 0001730463-23-000106 | Nov 9, 2023 | — |
| 10-Q | 10-Q | 0001730463-23-000110 | Nov 9, 2023 | Sep 30, 2023 |
| S-8 | S-8 | 0001193125-23-270356 | Nov 3, 2023 | — |
| 6-K | 6-K | 0001730463-23-000093 | Nov 2, 2023 | Sep 30, 2023 |
| S-8 | S-8 | 0001193125-23-205064 | Aug 7, 2023 | — |
| 6-K | 6-K | 0001730463-23-000079 | Aug 3, 2023 | Jun 30, 2023 |
| 6-K | 6-K | 0001730463-23-000060 | Jul 21, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-079699 | Jul 10, 2023 | — |
| 6-K/A | 6-K/A | 0001730463-23-000056 | Jul 7, 2023 | Jun 22, 2023 |
| 6-K | 6-K | 0001730463-23-000054 | Jul 6, 2023 | Jul 3, 2023 |
| 6-K | 6-K | 0001730463-23-000046 | Jun 20, 2023 | — |
| 6-K | 6-K | 0001730463-23-000039 | Jun 6, 2023 | — |
| 6-K | 6-K | 0001730463-23-000041 | Jun 6, 2023 | — |
| 6-K | 6-K | 0001730463-23-000029 | May 4, 2023 | Mar 31, 2023 |
| SC 13G | TETRAGON FINANCIAL MANAGEMENT LP | 0000902664-23-002311 | Mar 20, 2023 | — |
| 6-K | 6-K | 0001730463-23-000021 | Mar 14, 2023 | — |
| 20-F | 20-F | 0001730463-23-000016 | Mar 7, 2023 | Dec 31, 2022 |
| SC 13G/A | SC 13G/A | 0001193125-23-038093 | Feb 14, 2023 | — |
| SC 13G | — | 0001172661-23-001040 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-037734 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001172661-23-000823 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021913 | Feb 14, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0001422849-23-000005 | Feb 13, 2023 | — |
| 6-K | 6-K | 0001730463-23-000007 | Jan 23, 2023 | — |
| 6-K | 6-K | 0001193125-22-310163 | Dec 21, 2022 | — |
| SC 13G | — | 0001172661-22-002614 | Dec 19, 2022 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-22-012374 | Dec 13, 2022 | — |
| 424B5 | 424B5 | 0001193125-22-301909 | Dec 12, 2022 | — |
| 6-K | 6-K | 0001193125-22-301911 | Dec 12, 2022 | Dec 9, 2022 |
| 6-K | 6-K | 0001193125-22-301047 | Dec 8, 2022 | — |
| 424B5 | 424B5 | 0001193125-22-301031 | Dec 8, 2022 | — |
| 6-K/A | 6-K/A | 0001730463-22-000037 | Nov 21, 2022 | Sep 30, 2022 |
| 6-K | 6-K | 0001730463-22-000032 | Nov 3, 2022 | Sep 30, 2022 |
| SC 13D/A | AMENDMENT NO. 8 TO SCHEDULE 13D | 0001213900-22-062213 | Oct 5, 2022 | — |